Efficacy and Safety Study of the Fixed-dose Combination of Olmesartan + Indapamide When Compared to the Isolated Drugs in the Treatment of Hypertension.
Clinical trial NCT05110898 · UNKNOWN
Trial details
- NCT number
- NCT05110898
- Sponsor
- Brainfarma Industria Química e Farmacêutica S/A
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-08-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.